Pune, 7 August 2023: Cyrus Poonawalla Group, a diversified group of businesses across Pharmaceuticals & Biotechnology, Finance, Clean Energy, Hospitality & Realty and Aviation appoints Mr. Keki Mistry, former HDFC Ltd. CEO & Vice Chairman as the Strategic Advisor to all the Financial Services ventures spearheaded by Mr. Adar Poonawalla.
With over 4 decades of experience, Mr. Mistry is one of the most respected professionals in the Indian Financial Services industry. Mr. Mistry had served as the CEO and Vice Chairman of HDFC Ltd since 2010. Post its merger with HDFC Bank, he joined the bank as an Additional & Non- Executive Director (Non-Independent) on 30th June 2023. He is also the Non-Executive Chairman of HDFC Ergo General Insurance Company Limited.
Mr. Adar Poonawalla, Chairman Poonawalla Fincorp and CEO Serum Institute of India.
Welcoming Keki on board Mr. Adar Poonawalla, Chairman Poonawalla Fincorp and CEO Serum Institute of India said, “To begin with, Keki's unparalleled operating and boardroom experience in the Indian financial services sector will act as the perfect sounding board for all financial services business management teams to scale their profitability through prudent risk management while managing business volatility.”
Mr. Keki Mistry
Mr. Keki Mistry stated, “As I move out of executive responsibilities at HDFC Ltd - I am excited to guide the financial services businesses spearheaded by Adar in achieving their business plans whilst delivering responsible shareholder returns. I look forward to working with the young & dynamic management teams by leveraging my operating and board experience in financial services."
About Cyrus Poonawalla Group:
The Cyrus Poonawalla Group of Companies, based in Pune, India, spans Pharmaceuticals & Biotechnology, Finance, Clean Energy, Hospitality & Realty, and Aviation. Dr. Cyrus Poonawalla founded the Serum Institute of India in 1966, now led by CEO Adar Poonawalla as India's top biotech firm and the world's largest vaccine manufacturer. The group's diversified businesses include Poonawalla Fincorp, Poonawalla Clean Energy, and ventures in Hospitality & Realty. Adar established the Villoo Poonawalla Foundation in 2011, focusing on healthcare, education, clean water, sanitation, and environment initiatives.
email@example.com | firstname.lastname@example.org
Adar Poonawalla awarded 'Business Leader of the Year' 2023 by the International Advertising Association (IAA) India Chapter
Cyrus Poonawalla Group appoints Keki Mistry as Strategic Advisor to all the Financial Services Ventures led by Adar Poonawalla
R21/Matrix-M™ malaria vaccine developed by University of Oxford receives regulatory clearance for use in Ghana
Department of Biotechnology announces the scientific completion of India's first qHPV vaccine ‘CERVAVAC’
Adar Poonawalla, CEO, Serum Institute of India, receives the award for the Outstanding Business Leader of the Year
Novavax and Serum Institute of India Receive Emergency Use Authorization for COVID-19 Vaccine in the Philippines
Novavax and Serum Institute of India Receive Emergency Use Authorization for COVID-19 Vaccine in Indonesia
Serum Institute Of India sends out Covishield vaccine - Consignment of Covishield Vaccine arrived in Delhi, Chennai, Kolkata, Guwahati, Shillong, Ahmedabad, Hydrabad, Vijayawada, Bhubaneswar, Patna, Bengaluru, Lucknow, Chandigarh
Serum Institute of India launches India’s first fully indigenously developed pneumococcal vaccine, 'PNEUMOSIL'
Oxford COVID-19 vaccine: Serum Institute likely to submit final Covishield trial data within 10 days
SII’s Adar Poonawalla on Covid vaccine, pricing and rollout at Hindustan Times Leadership Summit 2020
COVISHIELD Completes Enrolment of Phase III clinical trials under partnership of ICMR and Serum Institute of India
Government Secures Vaccine Supplies For Half Of The Indian Population From Serum Institute And Novavax
IAVI, Merck, and Serum Institute of India Join Forces to Develop Monoclonal Antibodies for COVID-19 and Ensure Prompt and Equitable Global Access
Serum Institute Of India Takes A Multipronged Approach In Quest To Produce World’s First Covid-19 Vaccines
Serum Institute of India to produce up to an additional 100 million covid 19 vaccine doses for india and low and midle income countries in 2021
Adar Poonawalla CEO of Serum Institute of India, the world’s largest vaccine manufacturer, explains the timing, challenges & cost of vaccinating the world against COVID-19
Serum Institute looking for a $1 billion shot to fight covid, talks on with Blackstone, KKR and others
Serum Institute of India Says Covid Vaccine Likely to Be Ready by End of 2020, Final Pricing in 2 Months
Serum institute of india to produce up to 100 million covid-19 vaccine doses for india and low-and middle-income countries as early as 2021
50% of our Covid vaccines will be for India, people won't have to buy them, govts will pay: Adar Poonawalla
AstraZeneca vaccine's success in early human trials, Will Begin AstraZeneca Vaccine Trial in India After Applying for Licence Next Week, Says Serum Institute
Serum Institute of India CEO: ‘We plan to make millions of doses of Covid vaccine over three months’:’
New supply agreement between UNICEF and Serum Institute of India makes pneumococcal conjugate vaccine available at US$2.00 per dose, a 43 % reduction from the Gavi price at the start of the Advance Market Commitment
Serum Institute confident of manufacturing Covid vaccine’s 100 million doses if trials establish efficacy
Serum Institute’s Journey To Success | ET NOW Covid-19 vaccine possible by Q2 of 2022: Adar Poonawalla
Adar Poonawalla discusses Serum Institute's progress in the global battle against COVID-19 with Shereen Bhan, CNBC-TV18
Adar Poonawalla talks with Aabha Bakaya about the success story of Serum Institute of India. Tune in to know all about the journey of the company.
Bill Gates confers Indian Council of Medical Research "Lifetime Achievement Medal" on Dr. Cyrus Poonawalla
Dr. Cyrus Poonawalla conferred with 'Lifetime Achievement Award’ by the Asian Business Leadership Forum
Dr. Cyrus Poonawalla conferred with the prestigious honorary degree by the University of Oxford, U.K.